Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024
21 nov. 2023 06h00 HE
|
Greenwich LifeSciences, Inc.
STAFFORD, Texas, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an...